Hypothesis and Theory
Published on 25 May 2023
What makes TMB an ambivalent biomarker for immunotherapy? A subtle mismatch between the sample-based design of variant callers and real clinical cohort
in Cancer Immunity and Immunotherapy
- 2,343 views
- 6 citations